Sage Therapeutics (SAGE) shares surged nearly 38% in recent Monday premarket activity after it said late Friday Biogen (BIIB) had submitted an unsolicited, nonbinding proposal to acquire all outstanding shares of the company not already owned for $7.22 a share.
Intra-Cellular Therapies (ITCI) stock rose nearly 35% after it signed a definitive deal to be acquired by Johnson & Johnson (JNJ) for $132 per share in cash for a total equity value of about $14.6 billion, the companies said Monday.
Pediatrix Medical Group (MD) shares rose nearly 16% after saying it appointed Executive Chair Mark Ordan as chief executive officer, effective immediately.
Molecular Partners (MOLN) stock jumped 22%, after it expanded its strategic partnership with Orano Med to include the development of an additional six targeted alpha radio-therapies for cancer, the companies said Sunday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.